UBS Lowers UNH Target Amid Conservative 2025 Outlook from CEO

UnitedHealth Group Incorporated (NYSE:UNH) ranks among the best set-it-and-forget-it stocks to buy. While maintaining its Buy rating, UBS reduced its price target for UnitedHealth Group Incorporated (NYSE:UNH) from $400 to $385 on June 25. The adjustment followed remarks made by UnitedHealth’s returning CEO at the company’s June 2 annual meeting, when he stated that management would restore its 2025 projection during the second-quarter earnings release on July 29.

UBS Lowers UNH Target Amid Conservative 2025 Outlook from CEO

Ken Wolter/Shutterstock.com

UBS pointed out that the investment community has taken CEO Hemsley’s description of the forecast as “prudent” as a hint that guidance would be more conservative than the consensus of $22.50 earnings per share set on June 2. UBS recently revised its own predictions to reflect the recent movement in investor expectations toward a $20 EPS estimate for 2025.

UnitedHealth Group Incorporated (NYSE:UNH) is a renowned US multinational corporation that provides managed healthcare and insurance services. The company operates through four main segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx.

While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

Read More: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds

Disclosure: None.